Find clinical trials for Pancreatic Cancer in Birmingham, AL
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Pancreatic Cancer trials near Birmingham, AL, USA:
of borderline-resectable, locally-advanced , or medically inoperable pancreatic adenocarcinoma will translate into a decreased toxicity. The...
Birmingham, Alabama, United States and 2 other locations
This phase II study evaluates how well pemigatinib works for the treatment of adult patients with pancreatic cancer that has spread...
Phase 2
Birmingham, Alabama, United States and 108 other locations
to participants with locally advanced or metastatic solid tumors with certain KRAS mutations. LY4066434 will be given alone or in combinatio...
Phase 1
Birmingham, Alabama, United States and 57 other locations
and Pharmacodynamic Study of Minnelide™Capsules given daily for 21 days followed by 7 days off schedule in patients with Advanced Solid Tumors...
Phase 1
Birmingham, Alabama, United States and 6 other locations
* To evaluate the safety and tolerability of escalating doses of ERAS-007 in combination with other cancer therapies in study participants w...
Phase 1, Phase 2
Birmingham, Alabama, United States and 13 other locations
2 mutations. These include tumors in the colon or rectum, the uterus and the cervix (lower part of the uterus), the breast, the bladder, and...
Phase 2
Birmingham, Alabama, United States and 55 other locations
with gemcitabine, nab-paclitaxel (G-nP) or gemcitabine, nab-paclitaxel (G-nP) and atezolizumab in previously untreated subjects with metastatic pancreatic...
Phase 1
Birmingham, Alabama, United States
The purpose of this study is to find out whether the study drug, LY3537982, is safe and effective in cancer patients who have a specific gen...
Phase 1, Phase 2
Birmingham, Alabama, United States and 49 other locations
evaluate the safety, tolerability, drug levels, molecular effects, and clinical activity of MRTX849 (adagrasib) in patients with advanced solid tumors...
Phase 1, Phase 2
Birmingham, Alabama, United States and 231 other locations
in patients aged ≥ 18 years with locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC), non-small cell lung cancer...
Phase 1
Birmingham, Alabama, United States and 28 other locations
Clinical trials
Research sites
Resources
Legal